Table 2 Survival data for the patient group (n = 31)
Progression-free survival (PFS) | |
Progressions [n (%)] | 14 (45.2) |
3-year PFS (%) | 61.3 |
Range (months) | 6.2–47.8 |
Overall survival (OS) | |
Deaths [n (%)] | 9 (29.0) |
3-year OS (%) | 79.8 |
Range (months) | 14.9–52.9 |
Median follow-up (months) | 39.7 |